Influenza as an illness can cause severe complications and mess up anybody's medical history. Influenza is of various types and with a variety of deadly symptoms. Hence, early diagnosis of influenza can reduce the chances of further complications. Therefore, with World Health Organization (WHO) confirming about 600 million Influenza cases worldwide, the services offering accurate Influenza diagnosis are going to be in-demand always and become a part of a huge market in the medical sector.
Market Research Future (MRFR) has published a report about the global rapid influenza diagnostics tests market. This report expects 5.8% CAGR during the forecast period between 2017 and 2023. In terms of cash, this market is expected to grow with US $ 700.7 mn by 2023. This report analyzes the market, potential for growth during the forecast period, market sizes around the world, key players in the market, product launches and latest research and development (R&D). The global rapid influenza diagnostics market is on the basis of types, tests, and region. The segmentation of types comprises of type A flu, type B flu, type C flu. The three forms of type A are bird flu, seasonal flu, and Swine flu. On the basis of direct fluorescent antibody (DFA) tests, molecular tests, nucleic acid sequence-based amplification (NASBA) tests, rapid influenza detection tests (RIDT), serological assays, simple amplification-based assays (SAMBA) and loop-mediated isothermal amplification-based assays (LAMP). Serological assays are segmented into primary serological tests, secondary serological tests, and tertiary serological tests. Primary serological tests cover enzyme-linked immunosorbent assay (ELISA), immunofluorescent antibody technique (IFAT) and radioimmunoassay (RIA). Secondary Serological tests include agglutination tests, complement fixation tests (CFT), precipitation tests, serum neutralization tests (SNT) and toxin-antitoxin test.
Request Free Sample Copy at:
https://www.marketresearchfuture.com/sample_request/3142
Key Players
The key players in global rapid influenza diagnostics market include Alere (USA), BD (USA), Becton Dickinson (USA), BioMérieux SA (France), Cepheid (USA), Hardy Diagnostics(USA), LifeSign LLC.(USA), Meridian Bioscience, Inc.(USA), Quidel Corporation (USA), Roche Molecular Systems Inc.(Switzerland), and Sekisui Diagnostics (USA).
Latest Industry News
- Medical technology company Becton Dickinson (BD), currently a key player in global influenza diagnostics market, has formally opened a new research facility at Plassey Technological Park in Limerick. This business expansion has created 85 new jobs at its Irish operations. Currently, BD employs more than 1,300 employees in Ireland across Drogheda, Dun Laoghaire and its two sites in Limerick.
Browse Detailed TOC with COVID-19 Impact Analysis at:
https://www.marketresearchfuture.com/reports/influenza-diagnostics-market-3142
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), & Consulting Services. MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients.
Contact us:
Market Research Future (part of Wantstats Research and Media Private Limited),
99 Hudson Street, 5Th Floor,
New York, New York 10013
United States of America
+1 628 258 0071
Email: [email protected]
Rapid influenza diagnostic market tests (RIDTs) are type of immunoassays which identifies the presence of influenza A and B viral nucleoprotein antigens in respiratory specimens.
The RIDTs have received attention as it offers advantages over the other methods, for instance rapid result in less than approximately 15 minutes, high specificity and easy performance.
According to Centers for Disease Control and Prevention 2017 estimation, every year approximately 291,000 and 646,000 people die from seasonal influenza-related respiratory illness globally.Rapid influenza diagnostics market is expected to rise with a substantial CAGR in the forecast period of 2019-2026.
This rise in market value can be attributed to the rising number of geriatric population.This Rapid influenza diagnostics market report studies and analyses facts and figures about the market segmentation very carefully and represent it in the form of graphs for the better understanding of end user.
It not only identifies the emerging trends along with major drivers, challenges and opportunities in the market but also analyses them efficiently.
The market report has been specially designed by keeping in mind the customer requirements with which businesses can get assistance in increasing their return on investment (ROI).
